PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
08-Apr-2021 ETQ Announces 2021 Innovation Excellence Award Finalists Businesswire
08-Apr-2021 Hologic to Acquire Mobidiag, Innovator in Near-Patient, Acute Care Diagnostic Testing, for Approximately $795 Million Businesswire
08-Apr-2021 $24.97 Billion Expanded Polystyrene Market - Global Trends, Analysis, Growth and Forecast to 2025 - ResearchAndMarkets.com Businesswire
08-Apr-2021 CORRECTING and REPLACING: DS Biopharma and Nuvothera Enter Option and License Agreement for EPADILIN® Businesswire
08-Apr-2021 Global Nucleic Acid Isolation and Purification Market Analysis 2021-2026: Increasing R&D Activities as well as Technological Advancements and Increasing Automation - ResearchAndMarkets.com Businesswire
08-Apr-2021 Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults Businesswire
08-Apr-2021 Teva Canada annonce le lancement du nouvel auto-injecteur AJOVYMD pour le traitement préventif de la migraine chez les adultes Businesswire
08-Apr-2021 Dicerna Sells OXLUMO™ (lumasiran) Royalty Interest to Royalty Pharma for Up to $240 Million Businesswire
08-Apr-2021 Worldwide Formulation Development Outsourcing Industry to 2026 - Increasing Trend of Patent Protection Expiration of Major Drugs is Driving Growth - ResearchAndMarkets.com Businesswire
08-Apr-2021 BeiGene Launches BRUKINSA® (Zanubrutinib) in Canada for Patients with Waldenström’s Macroglobulinemia Businesswire
08-Apr-2021 ValenzaBio Advances Pipeline of Antibody Therapeutics Toward Clinical Development for Autoimmune and Inflammatory Diseases Businesswire
08-Apr-2021 BeiGene Provides Update on Phase 2 Clinical Trial of Zanubrutinib in Patients with COVID-19-Related Pulmonary Distress Businesswire
08-Apr-2021 Abiomed Fourth Quarter Fiscal 2021 Earnings and Conference Call Notification Businesswire
08-Apr-2021 Bristol Myers Squibb Announces Opdivo (nivolumab) plus Chemotherapy and Opdivo plus Yervoy (ipilimumab) Demonstrate Superior Survival Benefit Compared to Chemotherapy in Unresectable Advanced or Metastatic Esophageal Squamous Cell Carcinoma Businesswire
08-Apr-2021 Merck’s KEYTRUDA® (pembrolizumab) Demonstrated Superior Disease-Free Survival (DFS) Compared With Placebo as Adjuvant Therapy in Patients With Renal Cell Carcinoma (RCC) Following Surgery Businesswire
08-Apr-2021 Ventus Therapeutics Closes $100 Million Series B Financing Businesswire
08-Apr-2021 Global Benzene (Capacity, Supply & Demand) Market Insights & Forecast Report 2021-2025: High Benzene & Derivatives by Pharmaceutical Companies & Increasing Benzene Production Capacity Additions - ResearchAndMarkets.com Businesswire
08-Apr-2021 Healthcare Mobility Solutions Market Forecast to 2027 - Global COVID-19 Impact and Analysis by Products and Services, Application, and End User, and Geography - ResearchAndMarkets.com Businesswire
08-Apr-2021 Global Thin wall Packaging Market (2021 to 2026) - Growth, Trends, COVID-19 Impact, and Forecasts - ResearchAndMarkets.com Businesswire
08-Apr-2021 Galderma Announces Publication of Phase 2b Trial Results Demonstrating the Rapid and Long-lasting Benefits of Nemolizumab in Clinical Trial Subjects With Uncontrolled Atopic Dermatitis Businesswire